Research Advances in Mitophagy in Hepatic Ischemia-Reperfusion Injury

JCNR

Journal of Clinical and Nursing Research

2208-36852208-3693

Bio-Byword Scientific Publishing Pty. Ltd.

10.26689/jcnr.v9i7.11445

Article

Research Advances in Mitophagy in Hepatic Ischemia-Reperfusion Injuryhttps://artdesignp.com/journal/JCNR/9/7/10.26689/jcnr.v9i7.11445YangErhua,YangZhimeng,ZhaoDejiang,WangXuefeng

2025

2025-08-04

Hepatic ischemia-reperfusion injury (IRI) is a prevalent pathophysiological phenomenon encountered during liver surgeries and transplantation, leading to hepatocyte damage and liver dysfunction, which significantly affects patient prognosis. In recent years, the role of mitophagy in hepatic IRI has garnered considerable attention. Mitochondria, known as the "powerhouses" of the cell, are crucial for maintaining normal cellular physiological functions. During the ischemia-reperfusion process, mitochondria are susceptible to damage, generating excessive harmful substances, such as reactive oxygen species (ROS), which further exacerbate cellular injury. Mitophagy is a selective cellular self-protection mechanism that maintains the quality and quantity balance of mitochondria within cells by clearing damaged or dysfunctional mitochondria. In the context of liver IRI, the activation of mitophagy is of significant importance. On one hand, mitophagy can rapidly remove damaged mitochondria, thereby reducing the release of harmful products and alleviating oxidative stress and cellular damage. Research has indicated that under ischemia-reperfusion conditions, mitophagy-related pathways are activated, promoting the clearance of damaged mitochondria. On the other hand, mitophagy also regulates cellular energy metabolism, providing essential energy support for cells under stress. With the continuous advancement of research, the understanding of the role of mitophagy in hepatic IRI has become increasingly clear. Numerous studies are dedicated to exploring the specific molecular mechanisms of mitophagy and its regulation, aiming to develop new therapeutic strategies to alleviate hepatic IRI. Although studies have demonstrated that mitophagy has a protective effect in hepatic ischemia-reperfusion injury, many issues still require further investigation. First, it is essential to further elucidate the mechanisms underlying the role of mitophagy in ischemia-reperfusion. Additionally, understanding how to mitigate liver ischemia-reperfusion injury through the modulation of mitophagy represents a key focus for future research. Future studies may encompass drug development, gene therapy, and cell therapy approaches aimed at improving the prognosis of patients affected by liver ischemia-reperfusion.

Battaglioni S, Benjamin D, Wälchli M, et al., 2022, mTOR Substrate Phosphorylation in Growth Control. Cell, 185(11): 1814–1836.

Wullschleger S, Loewith R, Hall MN, 2006, TOR Signaling in Growth and Metabolism. Cell, 124(3): 471–484.

Szwed A, Kim E, Jacinto E, 2021, Regulation and Metabolic Functions of mTORC1 and mTORC2. Physiol Rev, 101(1): 137–192.

Mossmann D, Park S, Hall MN, 2018, mTOR Signalling and Cellular Metabolism Are Mutual Determinants in Cancer. Nat Rev Cancer, 18(12): 744–757.

Paquette M, El-Houjeiri L, Pause A, 2018, mTOR Pathways in Cancer and Autophagy. Cancers, 10(1): 18.

Murugan AK, 2019, mTOR: Role in Cancer, Metastasis and Drug Resistance. Semin Cancer Biol, 59: 92–111.

Ben-Sahra I, Manning BD, 2017, mTORC1 Signaling and the Metabolic Control of Cell Growth. Curr Opin Cell Biol, 45: 72–82.

Saxton RA, Sabatini DM, 2017, mTOR Signaling in Growth, Metabolism, and Disease. Cell, 168(6): 960–976.

Shimobayashi M, Hall MN, 2014, Making New Contacts: The mTOR Network in Metabolism and Signalling Crosstalk. Nat Rev Mol Cell Biol, 15(3): 155–162.

Jiang X, Overholtzer M, Thompson CB, 2015, Autophagy in Cellular Metabolism and Cancer. J Clin Invest, 125(1): 47–54.

Li X, He S, Ma B, 2022, Autophagy and Autophagy-Related Proteins in Cancer. Mol Cancer, 21(1): 1–29.

White E, Mehnert JM, Chan CS, 2015, Autophagy, Metabolism, and Cancer. Clin Cancer Res, 21(22): 5037–5046.

Yang A, Herter-Sprie GS, Zhang H, et al., 2018, Autophagy Sustains Pancreatic Cancer Growth Through Both Cell-Autonomous and Non-Autonomous Mechanisms. Cancer Discov, 8(3): 276–287.

Pópulo H, Lopes JM, Soares P, 2012, The mTOR Signalling Pathway in Human Cancer. Int J Mol Sci, 13(2): 1886–1918.

Ravikumar B, Sarkar S, Davies JE, et al., 2010, Regulation of Mammalian Autophagy in Physiology and Pathophysiology. Physiol Rev, 90(4): 1383–1435.

Jiang GM, Tan YZ, Wang H, et al., 2019, The Relationship Between Autophagy and the Immune System and Its Applications for Tumor Immunotherapy. Mol Cancer, 18(1): 1–17.

Palm W, Thompson CB, 2017, Nutrient Acquisition Strategies of Mammalian Cells. Nature, 546(7657): 234–242.

Saxton RA, Sabatini DM, 2017, mTOR Signaling in Growth, Metabolism, and Disease. Cell, 168(6): 960–976.

Xie Y, Zhou L, Xie Y, et al., 2020, mTOR Signaling Pathway in Cancer and Autophagy. Int J Mol Sci, 21(21): 7594.

Wei Y, Liu M, Li X, et al., 2020, Origin of the Autophagosome Membrane in Mammals. Biomed Pharmacother, 128: 110245.

Mercer TJ, Gubas A, Tooze SA, 2018, A Molecular Perspective of Mammalian Autophagosome Biogenesis. J Biol Chem, 293(15): 5386–5395.

Feng Y, He D, Yao Z, et al., 2014, The Machinery of Macroautophagy. Cell Res, 24(1): 24–41.

Parzych KR, Klionsky DJ, 2014, An Overview of Autophagy: Morphology, Mechanism, and Regulation. Antioxid Redox Signal, 20(3): 460–473.

Dikic I, Elazar Z, 2018, Mechanism and Medical Implications of Mammalian Autophagy. Nat Rev Mol Cell Biol, 19(6): 349–364.

Kim J, Kundu M, Viollet B, et al., 2011, AMPK and mTOR Regulate Autophagy Through Direct Phosphorylation of Ulk1. Nat Cell Biol, 13(2): 132–141.

Alers S, Löffler AS, Wesselborg S, et al., 2012, Role of AMPK–mTOR–Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks. Mol Cell Biol, 32(1): 2–11.

Hurley JH, Young LN, 2017, Mechanisms of Autophagy Initiation. Annu Rev Biochem, 86: 225–244.

Mizushima N, 2010, The Role of the Atg1/ULK1 Complex in Autophagy Regulation. Curr Opin Cell Biol, 22(2): 132–139.

Hosokawa N, Hara T, Kaizuka T, et al., 2009, Nutrient-Dependent mTORC1 Association with the ULK1–Atg13–FIP200 Complex Required for Autophagy. Mol Biol Cell, 20(7): 1981–1991.

Jung CH, Jun CB, Ro SH, et al., 2009, ULK–Atg13–FIP200 Complex: A New Regulator of mTOR Signaling and Autophagy. Cell, 137(7): 132–133.

Wong PM, Puente C, Ganley IG, et al., 2013, The ULK1 Complex: Sensing Nutritional Stress for Autophagy Activation. Autophagy, 9(2): 124–137.

Chan EY, Longatti A, McKnight NC, et al., 2009, Kinase-Inactivated ULK Proteins Inhibit Autophagy via Their Conserved C-Terminal Domains Using an Atg13-Independent Mechanism. Mol Cell Biol, 29(1): 157–171.

Egan DF, Shackelford DB, Mihaylova MM, et al., 2011, Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy. Science, 331(6016): 456–461.

Russell RC, Tian Y, Yuan H, et al. 2013, ULK1 Induces Autophagy by Phosphorylating Beclin-1 and Activating VPS34 Lipid Kinase. Nat Cell Biol, 15(7): 741–750.

He C, Levine B, 2010, The Beclin 1 Interactome. Curr Opin Cell Biol, 22(2): 140–149.

Kihara A, Noda T, Ishihara N, et al., 2001, Two Distinct Vps34 Phosphatidylinositol 3-Kinase Complexes Function in Autophagy and Carboxypeptidase Y Sorting in Saccharomyces cerevisiae. J Cell Biol, 152(3): 519–530.

Itakura E, Kishi C, Inoue K, et al., 2008, Beclin 1 Forms Two Distinct Phosphatidylinositol 3-Kinase Complexes with Mammalian Atg14 and UVRAG. Mol Biol Cell, 19(12): 5360–5372.

Obara K, Sekito T, Ohsumi Y, 2006, Assortment of Phosphatidylinositol 3-Kinase Complexes—Atg14p-Containing Complex Localizes to the Pre-Autophagosomal Structure. Autophagy, 2(6): 400–402.

Matsunaga K, Saitoh T, Tabata K, et al., 2009, Two Beclin 1-Binding Proteins, Atg14L and Rubicon, Reciprocally Regulate Autophagy at Different Stages. Nat Cell Biol, 11(4): 385–396.

Sun Q, Fan W, Chen K, et al., 2008, Identification of Barkor as a Mammalian Autophagy-Specific Factor for Beclin 1 and Class III Phosphatidylinositol 3-Kinase. Proc Natl Acad Sci USA, 105(49): 19211–19216.

Liang C, Lee JS, Inn KS, et al., 2008, Beclin1-Binding UVRAG Targets the Class C Vps Complex to Coordinate Autophagosome Maturation and Endocytic Trafficking. Nat Cell Biol, 10(7): 776–787.

Zhong Y, Wang QJ, Li X, et al. 2009, Distinct Regulation of Autophagic Activity by Atg14L and Rubicon Associated with Beclin 1–Phosphatidylinositol-3-Kinase Complex. Nat Cell Biol, 11(4): 468–476.

He C, Baba M, Klionsky DJ, 2009, Double Duty of Atg9 Self-Interaction in Autophagosome Biogenesis. Autophagy, 5(3): 385–387.

Young ARJ, Chan EYW, Hu XW, et al., 2006, Starvation and ULK1-Dependent Cycling of Mammalian Atg9 between the TGN and Endosomes. J Cell Sci, 119(18): 3888–3900.

Orsi A, Razi M, Dooley HC, et al., 2012, Dynamic and Transient Interactions of Atg9 with Autophagosomes, but Not Membranes Involved in Secretion or Endocytosis. Mol Biol Cell, 23(10): 1860–1873.

Yamada T, Carson AR, Caniggia I, et al., 2005, Endothelial Nitric-Oxide Synthase (eNOS) Is Regulated by a Histone H3K27 Demethylase, JMJD3, in Response to Hypoxia. J Biol Chem, 280(43): 43189–43195.

Ge L, Zhang M, Schekman R, 2014, Phosphatidylinositol 3-Kinase and COPII Generate LC3 Lipidation Vesicles from the ER-Golgi Intermediate Compartment. eLife, 3: e04135.

Ge L, Zhang M, Kenny SJ, Liu D, et al., 2017, Remodeling of ER–Exit Sites Initiates a Membrane Supply Pathway for Autophagosome Biogenesis. EMBO Rep, 18(9): 1586–1603.

Suzuki K, Kubota Y, Sekito T, et al., 2007, Hierarchy of Atg Proteins in Pre-Autophagosomal Structure Organization. Genes Cells, 12(2): 209–218.

Weidberg H, Shvets E, Elazar Z, 2011, Biogenesis and Cargo Selectivity of Autophagosomes. Annu Rev Biochem, 80: 125–156.

Axe EL, Walker SA, Manifava M, et al., 2008, Autophagosome Formation from Membrane Compartments Enriched in Phosphatidylinositol 3-Phosphate and Dynamin 2. Nat Cell Biol, 10(12): 1243–1250.

Nascimbeni AC, Codogno P, Morel E, 2017, Phosphatidylinositol-3-Phosphate in the Regulation of Autophagy Membranes. Front Cell Dev Biol, 5: 71.

Razi M, Chan EYW, Tooze SA, 2009, Early Endosomes and Endosome-Associated ER Subdomains Are Required for Autophagosome Formation. J Cell Biol, 185(2): 305–321.

Matsunaga K, Morita E, Saitoh T, et al., 2010, Autophagy Requires Endoplasmic Reticulum-Localized PI3K Complex for Pre-Autophagosomal Structure Formation. EMBO Rep, 11(11): 916–922.

Funderburk SF, Wang QJ, Yue Z, 2010, The Beclin 1–VPS34 Complex—At the Crossroads of Autophagy and Endocytic Trafficking. Autophagy, 6(5): 680–689.

Karanasios E, Walker SA, Okkenhaug H, et al., 2016, Autophagy Initiation by ULK Complex Assembly on ER Tubulovesicular Regions Marked by ATG9 Vesicles. Nat Commun, 7: 12420.

Yamamoto H, Kakuta S, Watanabe TM, et al., 2012, Atg9 Vesicles Are an Important Membrane Source during Early Steps of Autophagosome Formation. J Cell Biol, 198(2): 219–233.

Koyama-Honda I, Itakura E, Fujiwara TK, et al., 2013, Temporal Analysis of Recruitment of Mammalian ATG Proteins to the Autophagosome Formation Site. Autophagy, 9(10): 1491–1499.

Orsi A, Razi M, Dooley HC, et al., 2012, Dynamic and Transient Interactions of Atg9 with Autophagosomes, but Not Membranes Involved in Secretion or Endocytosis. Mol Biol Cell, 23(10): 1860–1873.

Takahashi Y, Takabatake Y, Kimura T, et al., 2011, Loss of Autophagy in Dopaminergic Neurons Causes Lewy Body Formation and Motor Dysfunction in Mice. J Clin Invest, 121(7): 2395–2407.